Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Prevalence of Patent Foramen Ovale in Patients with Stroke
19881.2k citationsG Lascault, G Drobinski et al.profile →
Right ventricular dysplasia: a report of 24 adult cases.
19821.1k citationsG Fontaine, G Guiraudon et al.Circulationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Y Grosgogeat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Grosgogeat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Grosgogeat more than expected).
This network shows the impact of papers produced by Y Grosgogeat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Grosgogeat. The network helps show where Y Grosgogeat may publish in the future.
Co-authorship network of co-authors of Y Grosgogeat
This figure shows the co-authorship network connecting the top 25 collaborators of Y Grosgogeat.
A scholar is included among the top collaborators of Y Grosgogeat based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Y Grosgogeat. Y Grosgogeat is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bonnefont‐Rousselot, Dominique, et al.. (1993). Le traitement antioxydant dans l'ischémie reperfusion myocardique. Archives Des Maladies Du Coeur Et Des Vaisseaux. 86. 105–109.2 indexed citations
Frank, Robert, et al.. (1983). Tachycardie supraventriculaire rebelle. Interruption thérapeutique du faisceau de His par choc électrique.. La Presse Médicale. 12(14). 899–900.1 indexed citations
16.
Vedel, J. P., et al.. (1978). Electrocardiologie de quatre cas de dysplasie ventriculaire droite arythmogène.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 71(9).61 indexed citations
17.
Frank, Richard G., et al.. (1978). [Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 71(9). 963–72.51 indexed citations
18.
Grosgogeat, Y, et al.. (1977). La biopsie endomyocardique: son intérêt en pathologie tropicale. A propos de 3 nouveaux cas. Archives Des Maladies Du Coeur Et Des Vaisseaux. 70(2).1 indexed citations
Even, P, et al.. (1965). Cardiopathie carcinoïde (nouvelle observation clinique, hémodynamique, biologique et anatomique). Archives Des Maladies Du Coeur Et Des Vaisseaux. 58(11).5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.